Oleg Akilov, Auris Huen, Barbara Pro, Dipenkumar Modi, Ann Mohrbacher, Brad M. Haverkos, Lou Scarmoutzos, Michael Charles Burns, Earle Holsapple, Ken Massey, Ralph E. Parchment, Yamini Donekal, Ali Moiin. "A phase 1a/1b trial in relapsed/refractory T-cell non-Hodgkin lymphoma to determine the safety profile, pharmacology, and maximum tolerated dose of ST-001, an intravenous fenretinide phospholipid suspension (12.5 mg/mL).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps7096